Loading the records…
Loading the records…
Veterans Affairs · 248-NETWORK CONTRACT OFFICE 8 (36C248)
Veterans Affairs is planning to buy "FY27 Cxbladder Molecular Diagnostic Testing". This is an early notice: it is not taking bids yet. Responses are due Nov 23, 2026. In the last 2 years, similar work went to 2 companies, usually for about $277K per award. An award is expected between January 2027 and March 2027.
Put together from the facts on this page; the details and sources are below.
Your briefs and their views: My briefs.
Every notice posted under solicitation 36C24827Q0133 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
ides clinically relevant molecular information to support diagnostic clarification, risk stratification, surveillance, and informed treatment decisions. JAHVAMC seeks a firm fixed-price, cost-per-test contract consisting of one 12-month base period and four 12-month option periods. The Contractor shall furnish Cxbladder Triage® and Cxbladder Monitor® testing, including all required test kits, collection and shipping materials, specimen transportation, laboratory analysis, result reporting, technical support, and secure electronic access to finalized test results. 2. SCOPE: 2.1 The Contractor shall furnish all labor, materials, equipment, supplies, shipping services, technical expertise, reporting capabilities, and administrative support necessary to perform Cxbladder Triage and Cxbladder Monitor testing for JAHVAMC, located in Tampa, Florida. Cxbladder Triage and Cxbladder Monitor testing support the clinical evaluation and management of patients who may be at risk for urothelial carcinoma. 2.2 Cxbladder Triage assists clinicians in identifying patients who may require further diagnostic evaluation for urothelial carcinoma. The test supports risk assessment and may help reduce unnecessary invasive diagnostic procedures in patients with a low likelihood of malignancy. 2.3 Cxbladder Monitor supports surveillance of patients with a history of urothelial carcinoma by identifying molecular signals associated with possible recurrent or progressive disease. The test assists clinicians in determining the appropriate level and timing of follow-up evaluation. Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. 2.4 Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this Special Notice. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511 Medical Laboratories with a size standard of $36.5 Million. Any offeror capable of providing this service shall notify the Contracting Officer by email within seven (7) calendar days from the date of the publication of this special notice. *Responses must include written documentation from the OEM, Pacific Edge Diagnostics USA Ltd., showing your company is an authorized service provider. All information is to be submitted no later than 2:00 PM EST, on Tuesday, November 23, 2026, to: keila.president@va.gov.
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (248-NETWORK CONTRACT OFFICE 8 (36C248)), same product/service code (PSC) Q301.
Single-winner award sizes (3): middle half $277K to $376K, median $277K; range $277K to $475K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| I-2-I Solutions, Inc. | 2 | $555K | Feb 20, 2025 |
| BITSCOPIC INC | 1 | $475K | Oct 1, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
None of these past winners filed lobbying reports naming Veterans Affairs, Dept of (VA) since 2024. No sign of an incumbent lobbying push at this agency.
No lobbyist on these filings lists a past Veterans Affairs, Dept of (VA) job: no revolving-door tie found in these filings. (These are lobbyists the companies pay, not their own staff.)
None of these winners matched a listed company, so PAC and FARA checks did not run.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
No bills named on these filings under Veterans Affairs-related issues.
A bill's title is shown only when the filing's own text names it; filings often cite last Congress's bill numbers.
No executive order in the last 12 months names Veterans Affairs in its title or summary.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
None of the past winners matched a listed company.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.